Valuation: ConvaTec Group PLC

Market Cap 5.99B 104B 5.22B 4.87B 4.48B 8.41B 573B 8.61B 57.68B 22.58B 284B 22.48B 21.99B 978B P/E 2026 *
21.7x
P/E 2027 * 17x
Enterprise Value 7.19B 125B 6.27B 5.85B 5.38B 10.09B 687B 10.34B 69.23B 27.1B 341B 26.98B 26.4B 1,174B EV / Sales 2026 *
2.8x
EV / Sales 2027 * 2.57x
Free-Float
95.19%
Yield 2026 *
2.56%
Yield 2027 * 2.87%
1 year 59.76
Extreme 59.76
59.76
3 years 57.13
Extreme 57.13
74.97
5 years 57.13
Extreme 57.13
74.97
10 years 57.13
Extreme 57.13
74.97
Manager TitleAgeSince
Chief Executive Officer 62 2025-08-03
Director of Finance/CFO 51 2025-08-03
Chief Operating Officer - 2026-05-31
Director TitleAgeSince
Director/Board Member 71 2017-08-13
Chairman 78 2019-09-29
Director/Board Member 62 2020-03-01
Change 5-day change 1-year change 3-year change Capi.($)
-1.16%-.--% - - 5.93B
+0.68%+8.36%-14.52%-4.20% 187B
+0.76%+6.30%-4.82%-0.80% 111B
-0.30%+5.13%+11.32%+70.78% 62.18B
+0.34%-6.62%+21.84%+49.32% 48.4B
+1.24%+9.46%-7.95%-39.93% 45.83B
-1.06%+2.53% - - 34.26B
+0.39%+0.52%-16.07%-43.24% 28.88B
+0.20%-6.06%+30.92%-7.66% 23.72B
+1.95%+10.90%+3.66%+2.08% 22.45B
Average +0.30%+1.84%+3.05%+3.30% 62.64B
Weighted average by Cap. +0.50%+4.12%-2.83%+5.10%

Financials

2026 *2027 *
Net sales 2.57B 44.74B 2.24B 2.09B 1.92B 3.6B 245B 3.69B 24.72B 9.68B 122B 9.63B 9.42B 419B 2.74B 47.73B 2.39B 2.23B 2.05B 3.84B 262B 3.94B 26.37B 10.32B 130B 10.28B 10.05B 447B
Net income 275M 4.8B 240M 224M 206M 386M 26.31B 396M 2.65B 1.04B 13.03B 1.03B 1.01B 44.94B 354M 6.17B 309M 288M 265M 497M 33.84B 509M 3.41B 1.33B 16.76B 1.33B 1.3B 57.8B
Net Debt 1.2B 20.92B 1.05B 976M 898M 1.68B 115B 1.73B 11.56B 4.52B 56.84B 4.5B 4.41B 196B 1.03B 18.04B 902M 842M 774M 1.45B 98.93B 1.49B 9.96B 3.9B 49B 3.88B 3.8B 169B
Logo ConvaTec Group PLC
ConvaTec Group Plc specializes in the development, manufacturing and marketing of medical devices and products for ostomy care, wound care, and incontinence. The group also offers perfusion devices. Net sales break down by area of activity as follows: - wound care (30.9%): antimicrobial dressings, occlusive dressings, compression bandages, etc.; - ostomy care (27.7%): skin barriers, one-piece bags, 2-piece appliance bags, urostomy bags, etc.; - incontinence care (22%); - infusion (19.4%). At the end of 2025, the group operated 7 production sites worldwide. Net sales are distributed geographically as follows: Europe (29.6%), North Americas (55.7%) and other (14.7%).
Employees
10,910
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
18
Last Close Price
3.036USD
Average target price
3.986USD
Spread / Average Target
+31.30%

Quarterly revenue - Rate of surprise